BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20513254)

  • 1. Risk factors for 30-day mortality in patients with carbapenem-resistant Acinetobacter baumannii during an outbreak in an intensive care unit.
    Prates CG; Martins AF; Superti SV; Lopes FS; Ramos F; Cantarelli VV; Zavascki AP
    Epidemiol Infect; 2011 Mar; 139(3):411-8. PubMed ID: 20513254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outbreak of resistant Acinetobacter baumannii- measures and proposal for prevention and control.
    Romanelli RM; Jesus LA; Clemente WT; Lima SS; Rezende EM; Coutinho RL; Moreira RL; Neves FA; Brás Nde J
    Braz J Infect Dis; 2009 Oct; 13(5):341-7. PubMed ID: 20428632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO
    J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
    Oliveira MS; Prado GV; Costa SF; Grinbaum RS; Levin AS
    J Antimicrob Chemother; 2008 Jun; 61(6):1369-75. PubMed ID: 18367459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates.
    Kopterides P; Koletsi PK; Michalopoulos A; Falagas ME
    Int J Antimicrob Agents; 2007 Nov; 30(5):409-14. PubMed ID: 17851052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endemic carbapenem-resistant Acinetobacter baumannii in a Brazilian intensive care unit.
    dos Santos Saalfeld SM; Fukita Viana G; Dias Siqueira VL; Cardoso CL; Botelho Garcia L; Bronharo Tognim MC
    J Hosp Infect; 2009 Aug; 72(4):365-8. PubMed ID: 19541388
    [No Abstract]   [Full Text] [Related]  

  • 7. A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia.
    Nutman A; Glick R; Temkin E; Hoshen M; Edgar R; Braun T; Carmeli Y
    Clin Microbiol Infect; 2014 Dec; 20(12):O1028-34. PubMed ID: 24930471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection.
    del Mar Tomas M; Cartelle M; Pertega S; Beceiro A; Llinares P; Canle D; Molina F; Villanueva R; Cisneros JM; Bou G
    Clin Microbiol Infect; 2005 Jul; 11(7):540-6. PubMed ID: 15966971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for carbapenem-resistant Acinetobacter baumannii infections at a tertiary care hospital in New Caledonia, South Pacific.
    Le Hello S; Falcot V; Lacassin F; Mikulski M; Baumann F
    Scand J Infect Dis; 2010 Dec; 42(11-12):821-6. PubMed ID: 20560868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of carbapenem resistance on clinical and economic outcomes among patients with Acinetobacter baumannii infection in Colombia.
    Lemos EV; de la Hoz FP; Alvis N; Einarson TR; Quevedo E; Castañeda C; Leon Y; Amado C; Cañon O; Kawai K
    Clin Microbiol Infect; 2014 Feb; 20(2):174-80. PubMed ID: 23668595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand.
    Anunnatsiri S; Tonsawan P
    Southeast Asian J Trop Med Public Health; 2011 May; 42(3):693-703. PubMed ID: 21706949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality attributable to carbapenem-resistant nosocomial Acinetobacter baumannii infections in a Turkish university hospital.
    Aydemir H; Celebi G; Piskin N; Oztoprak N; Keskin AS; Aktas E; Sumbuloglu V; Akduman D
    Jpn J Infect Dis; 2012; 65(1):66-71. PubMed ID: 22274161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia.
    Zheng YL; Wan YF; Zhou LY; Ye ML; Liu S; Xu CQ; He YQ; Chen JH
    Am J Infect Control; 2013 Jul; 41(7):e59-63. PubMed ID: 23523521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbapenem-resistant Acinetobacter baumannii: diversity of resistant mechanisms and risk factors for infection.
    Kim YJ; Kim SI; Kim YR; Hong KW; Wie SH; Park YJ; Jeong H; Kang MW
    Epidemiol Infect; 2012 Jan; 140(1):137-45. PubMed ID: 21554783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors associated with mortality in Acinetobacter baumannii infected intensive care unit patients].
    Karabay O; Yahyaoğlu M; Oğütlü A; Sandıkçı O; Tuna N; Ceylan S
    Mikrobiyol Bul; 2012 Apr; 46(2):335-7. PubMed ID: 22639324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii.
    Sheng WH; Liao CH; Lauderdale TL; Ko WC; Chen YS; Liu JW; Lau YJ; Wang LH; Liu KS; Tsai TY; Lin SY; Hsu MS; Hsu LY; Chang SC
    Int J Infect Dis; 2010 Sep; 14(9):e764-9. PubMed ID: 20646946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential susceptibility to carbapenems due to the AdeABC efflux pump among nosocomial outbreak isolates of Acinetobacter baumannii in a Chinese hospital.
    Huang L; Sun L; Xu G; Xia T
    Diagn Microbiol Infect Dis; 2008 Nov; 62(3):326-32. PubMed ID: 18687557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
    Huang ST; Chiang MC; Kuo SC; Lee YT; Chiang TH; Yang SP; Ti-Yin ; Chen TL; Fung CP
    J Microbiol Immunol Infect; 2012 Oct; 45(5):356-62. PubMed ID: 22575430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensively drug-resistant Acinetobacter baumannii: risk factors for acquisition and prevalent OXA-type carbapenemases--a multicentre study.
    Park YS; Lee H; Lee KS; Hwang SS; Cho YK; Kim HY; Uh Y; Chin BS; Han SH; Jeong SH; Lee K; Kim JM
    Int J Antimicrob Agents; 2010 Nov; 36(5):430-5. PubMed ID: 20864318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.